Advanced search

Filters

Country

All countries

North America

South America

Europe

Africa

Middle East

Asia

Oceania

Central America

Select all

Capitalization

Sector

All sectors

  Energy

  Basic Materials

  Industrials

  Consumer Cyclicals

  Consumer Non-Cyclicals

  Financials

  Healthcare

  Technology

  Utilities

  Real Estate

  Institutions, Associations & Organizations

  Government Activity

  Academic & Educational Services

Select all

Add a keyword

Announcement Date

Since

Until

718 Results

Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : LyondellBasell Industries N.V., Q1 2024 Earnings Call, Apr 26, 2024
Transcript : Federated Hermes, Inc. - Shareholder/Analyst Call
Transcript : Hawaiian Holdings, Inc., Q1 2024 Earnings Call, Apr 23, 2024
Transcript : Delta Air Lines, Inc., Q1 2024 Earnings Call, Apr 10, 2024
Rio Tinto : AGM 2024 - Address by the Chair
PU
Transcript : Rio Tinto Group - Shareholder/Analyst Call
Rio Tinto: paid $8.5 billion in taxes and royalties in 2023
CF
Rio Tinto releases details of $8.5 billion of taxes and royalties paid in 2023
BU
Centene : Political Activity Report July 1, 2023 – December 31, 2023
PU
Merck Provides Update on Phase 3 KEYLYNK-006 Trial Evaluating KEYTRUDA plus Maintenance LYNPARZA for Certain Patients with Metastatic Nonsquamous Non-Small Cell Lung Cancer
AQ
Transcript : Brown-Forman Corporation - Analyst/Investor Day
Transcript : Brown-Forman Corporation, Q3 2024 Earnings Call, Mar 06, 2024
Harpoon Therapeutics : March 6, 2024
PU
Transcript : Evolv Technologies Holdings, Inc., Q4 2023 Earnings Call, Feb 29, 2024
Transcript : Huntsman Corporation, Q4 2023 Earnings Call, Feb 22, 2024
Trending : Rio Tinto Cuts Dividend as Profit Hurt by Lower Aluminum, Copper Prices
DJ
Rio Tinto Annual Net Profit Down 19%, Dividend Pared on Commodity Price Fall -- Update
DJ
Transcript : Rio Tinto Group, 2023 Earnings Call, Feb 21, 2024
Transcript : Linde plc, Q4 2023 Earnings Call, Feb 06, 2024
Transcript : LyondellBasell Industries N.V., Q4 2023 Earnings Call, Feb 02, 2024
Transcript : Hawaiian Holdings, Inc., Q4 2023 Earnings Call, Jan 30, 2024
Alexandria Real Estate Equities, Inc. Reports: 4Q23 Net Loss per Share - Diluted of $0.54; 2023 Net Income per Share - Diluted of $0.54; and 4Q23 and 2023 FFO per Share - Diluted, As Adjusted, of $2.28 and $8.97, respectively
PR
Browning West Reacts to the Gildan Activewear Board’s Attempt to Simultaneously Delay and Cancel a Validly Requisitioned Special Meeting
BU
Browning West Discloses Gildan Activewear’s Efforts to Deprive Shareholders of an Opportunity to Reconstitute the Board at a Validly Requisitioned Special Meeting
BU
FDA Approves Merck's KEYTRUDA plus Chemoradiotherapy as Treatment for Patients with FIGO 2014 Stage III-IVA Cervical Cancer
AQ
Browning West Requisitions Special Meeting of Gildan Activewear Shareholders to Reconstitute a Majority of the Board of Directors
BU
REUTERS-SCHEDULE/…
RE
Electra Battery Materials Corporation Announces Chief Financial Officer Changes
CI
Electra Appoints 30-year Finance Veteran as CFO and Provides Financing Update
BU
Transcript : Melbana Energy Limited - Special Call
Merck Announces Findings from Phase 2 KeyVibe-002 Trial Evaluating an Investigational Coformulation of Vibostolimab and Pembrolizumab in Previously Treated Patients with Metastatic Non-Small Cell Lung Cancer
AQ
Merck Announces KEYLYNK-008 Trial Evaluating KEYTRUDA Plus LYNPARZA for Patients with Metastatic Squamous Non-Small Cell Lung Cancer to Stop for Futility
AQ
Transcript : Verint Systems Inc., Q3 2024 Earnings Call, Dec 06, 2023
Transcript : Brown-Forman Corporation, Q2 2024 Earnings Call, Dec 06, 2023
Transcript : Rio Tinto Group - Special Call
Alaska Air : Announcement Transcript
PU
Transcript : Alaska Air Group, Inc., Hawaiian Holdings, Inc. - M&A Call
Merck's V116, an Investigational, 21-valent Pneumococcal Conjugate Vaccine Specifically Designed to Protect Adults, Demonstrated Superior Immunogenicity for 10 of 11 Unique Serotypes Compared to PCV20 in Adults 50 Years of Age and Older
AQ
Transcript : Genetic Technologies Limited - Shareholder/Analyst Call
Merck : Provides Update on FDA Advisory Committee Meeting Evaluating Gefapixant
PU
Rithm Capital Corp. completed the acquisition of Sculptor Capital Management, Inc. from shareholders.
CI
Transcript : Evolv Technologies Holdings, Inc., Q3 2023 Earnings Call, Nov 09, 2023
A strategic consortium led by Cameco Corporation, Brookfield Renewable Partners L.P. (TSX:BEP.UN) and Brookfield Global Transition Fund I, managed by Brookfield Asset Management Inc. (TSX:BAM.A) completed the acquisition of Westinghouse Electric Company LLC from Brookfield Business Partners L.P. and others.
CI
Merck - KEYTRUDA Significantly Improved Overall Survival versus Placebo as Adjuvant Therapy for Certain Patients with Renal Cell Carcinoma Following Nephrectomy
AQ
Transcript : Huntsman Corporation, Q3 2023 Earnings Call, Nov 01, 2023
Transcript : LyondellBasell Industries N.V., Q3 2023 Earnings Call, Oct 27, 2023
Transcript : Linde plc, Q3 2023 Earnings Call, Oct 26, 2023
Transcript : Hawaiian Holdings, Inc., Q3 2023 Earnings Call, Oct 24, 2023
Merck - European Commission Approves KEYTRUDA as Adjuvant Treatment for Adults with Non-Small Cell Lung Cancer at High Risk of Recurrence Following Complete Resection and Platinum-Based Chemotherapy
AQ
Transcript : Delta Air Lines, Inc., Q3 2023 Earnings Call, Oct 12, 2023
No results for this search
  1. Stock Market
  2. Advanced search
  3. Peter Cunningham
  4. News